ERIN HICKS: Open Payments
NPI 1912453200 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 40 payments from 12 companies in 2025. Trend: 2023 $813 · 2024 $1,151 · 2025 $655
Food & beverage: $546Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $211 |
| ABBVIE INC. | 18 | $178 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| GENZYME CORPORATION | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| LNHC, Inc | 1 | $22 |
| LEO Pharma Inc. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
Products named: TREMFYA, SKYRIZI, ILUMYA, DUPIXENT, RINVOQ, Rhapsido, ACTHAR, ZELSUVMI.
Industry payments across IN — which companies pay providers there.
